Frequent but late donor-directed antibody formation after kidney transplantectomy within one month after grafting

Transplantation

Volumn 81, Issue 4, 2006, Pages 614-619

  Lenaers, Jo ^a   Christiaans, Maarten ^a   Van Heurn, Ernst ^a   Van Hooff, Hans ^a   Van Den Berg Loonen, Ella ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DACLIZUMAB; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TSUKUBAENOLIDE;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; CYTOTOXICITY; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT FAILURE; HUMAN; HUMAN TISSUE; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; PATIENT; PATIENT REFERRAL; PRIORITY JOURNAL; RETRANSPLANTATION; RETROSPECTIVE STUDY; SCREENING; SERUM;

ADOLESCENT; ADULT; AGED; ANTIBODY FORMATION; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33644610767     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000196726.91957.97     Document Type: Article

References (28)

1. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti-class I response: clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992; 53(3): 550.
2. McKenna RM, Takemoto SK, Terasaki PI. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000; 69(3): 319.
3. Morris PJ, Williams GM, Hume DM, et al. Serotyping for homotransplantation. Transplantation 1968; 6(3): 392.
4. Lee P-C, Terasaki PI, Takemoto SK, et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002; 74(8): 1192.
5. Piazza A, Poggi E, Borrelli L, et al. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques. Transplantation 2001; 71(8): 1106.
6. Müller-Steinhardt M, Fricke L, Kirchner H, et al. Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation. Clin Transplant 2000; 14: 85.
7. Martin S, Dyer PA, Mallick NP, et al. Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome. Transplantation 1987; 44(1): 50.
8. Scornik JC, Salomon DR, Lim PB, et al. Posttransplant antidonor antibodies and graft rejection. Transplantation 1989; 47(2): 287.
9. Trpkov K, Campbell P, Pazderka F, et al. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplantation 1996; 61(11): 1586.
10. Worthington JE, Martin S, Al-Husseini DM, et al. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003; 75(7): 1034.
11. Christiaans M, Overhof-Roos de R, Nieman F, et al. Donor-specific antibodies after transplantation by flow cytometry. Transplantation 1998; 65(3): 427.
12. Abe M, Kawai T, Futatsuyama K, et al. Postoperative production of anti-donor antibody and chronic rejection in renal transplantation. Transplantation 1997; 63(11): 1616.
13. Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant 2004; 4: 438.
14. Taylor CJ, Ting A, Morris PJ. Production and characterization of human monoclonal lymphocytotoxic autoantibodies from a renal dialysis patient. Tissue Antigens 1991; 37(3): 112.
15. Groth J, Schönemann C, Kaden J, May G. Dynamics of donor-reactive IgG, IgA and IgM antibodies against T and B lymphocytes early after clinical kidney transplantation using flow cytometry. Transpl Immunol 1996; 4: 215.
16. Doran TJ, Süsal C, Opelz G, Greczy AF. IgA class antibodies and flow cytometric crossmatching in renal transplantation. Transplantation 1999; 67(2): 309.
17. Keizer KM, Fijter de JW, Haase-Kromwijk BJJM, Weimar W. Non-heart-beating donor kidneys in the Netherlands: allocation and outcome of transplantation. Transplantation 2005; 79(9): 1195.
18. Renkens JJM, Rouflart MMJ, Christiaans M, et al. Outcome of non-heart-beating donor kidneys with prolonged delayed graft function after transplantation. Am J Transplant 2005; 5(11): 2704.
19. Diepenhorst P, Engelfriet CP. Suspensions by filtration through cotton wool (Results after transfusion of 1,820 units of filtered erythrocytes). Vox Sang 1975; 29: 15.
20. Sirchia G, Rebulla P, Mascaretti L, et al. The clinical importance of leukocyte depletion in regular erythrocyte transfusions. Vox Sang 1986; 51(1): 2.
21. Scornik JC, Ireland JE, Howard RJ, et al. Role of regular and leukocyte-free blood transfusions in the generation of broad sensitization. Transplantation 1984; 38: 594.
22. Martin L, Guignier F, Bocrie O, et al. Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy. Transplantation 2005; 79(10): 1459.
23. Anderson JB, Fuller TC, Hawkins JA, et al. Two-year reduction of panel reactive human leukocyte antigen antibodies in children receiving mycophenolate mofetil after valved allograft placement. Transplantation 2005; 80(3): 414.
24. Terasaki PI, Gjertson DW, Cecka JM, et al. Significance of the donor age effect on kidney transplants. Clin Transplant 1997; 11: 366.
25. Morris PJ, Johnson RJ, Fuggle SV, et al. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. The Lancet 1999; 354: 1147.
26. Fijter de JW, Mallat MJK, Doxiadis IIM, et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001; 12: 1538.
27. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S. Fit and match hypothesis for kidney transplantation. Transplantation 1996; 62 (4): 441.
28. Halloran PF, Hornik J, Goes N, et al. The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 1997; 29: 79.